INFORMED.
LIVE

Kilitch Drugs (I) Ltd.

BSE: KILITCH524500ISIN INE729D01010
  • Healthcare
  • Pharmaceuticals

Share price

₹193.80+2.70 (+1.41%)
as of 18 Sep 2026
Kilitch Drugs (I) Ltd. share price, 18 Sep 2025 to 18 Sep 2026: ₹363.35 to ₹193.80 (-46.7%). Low ₹126.60, high ₹401.10. Volume shown below the price.
52W high
₹439.35
52W low
₹121.10
Off 52W high
-55.89%
1M return
+21.47%
3M return
+4.59%
6M return
-38.49%
1Y return
-46.66%
20D avg volume
2,024
50 DMA
₹180.78
200 DMA
₹235.86

Key ratios Consolidated

Market cap
₹677.56 Cr
Current price
₹193.80
52W high / low
₹439.35 / ₹121.10
Face value
₹10.00
P/E
23.20
P/B
EPS (TTM)
₹8.35
Book value / share
ROE
ROCE
13.20%
Operating margin
Net margin
Debt / equity
0.32
Net debt
₹72.94 Cr
Interest cover
7.95
Dividend yield
Dividend / share (TTM)
Payout
Cash conversion cycle
80.7 days

Financials

MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q4 FY24
Income statement
44.8889.6053.8148.9243.1461.23
2.900.491.536.662.561.70
43.9169.8849.7446.1942.2549.08
23.9242.6932.6024.2926.2230.15
0.000.000.000.000.000.00
4.144.293.513.762.752.88
0.881.441.151.441.531.60
1.090.980.940.860.840.85
14.0919.0213.2613.7611.6615.05
3.8620.215.609.403.4513.84
0.000.000.000.000.000.00
3.8620.215.609.403.4513.84
1.905.331.281.361.193.63
1.9714.884.328.042.2610.22
0.834.242.504.971.886.47
Key metrics
5.8322.637.6911.705.8216.29
13.00%25.30%14.30%23.90%13.50%26.60%
4.40%16.60%8.00%16.40%5.20%16.70%
6.40%3.40%6.80%
4.00%46.30%
-12.80%45.60%
MetricTTMFY26FY25FY24
Income statement
237.21235.47198.32
11.5811.2411.16
209.72208.06175.00
123.50125.07105.75
0.000.000.00
15.7014.3111.32
4.915.565.04
3.873.623.11
60.1358.4450.95
39.0738.6534.47
0.000.000.00
39.0738.6534.47
9.879.159.53
29.2129.5024.94
12.548.9116.60
Key metrics
47.8547.8342.62
20.17%20.30%21.50%
12.31%12.50%12.60%
13.20%17.30%
18.70%
18.30%
-75.5517.54
0.810.70
0.320.25
72.9439.62
80.784.5
Balance sheet
457.75312.78
222.20173.92
15.779.80
120.1884.74
11.5215.31
21.7314.47
48.7045.52
79.6554.16
121.6084.31
88.7149.42
30.1121.65
58.6027.77
276.87200.46
Cash flow
23.9617.54
-100.44-39.95
82.4513.24
99.510.00
MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q4 FY24
Income statement
40.9171.9744.6737.8134.1256.30
3.551.141.617.613.502.32
37.5153.7840.1135.3531.6443.63
20.2528.5325.3215.6818.2727.13
0.000.000.000.000.000.00
3.523.613.043.282.402.58
0.490.580.600.680.590.72
0.760.700.560.530.500.51
12.6918.8812.2913.1110.6514.14
6.9519.336.1710.075.9815.00
0.000.000.000.000.000.00
6.9519.336.1710.075.9815.00
1.905.331.281.361.193.62
5.0514.004.898.724.7911.37
1.454.082.745.272.987.07
Key metrics
8.2020.617.3311.287.0716.23
20.00%28.60%16.40%29.80%20.70%28.80%
12.30%19.50%10.90%23.10%14.00%20.20%
5.10%2.90%5.60%
19.90%27.80%
5.40%23.10%
MetricTTMFY26FY25FY24
Income statement
195.36188.57181.59
13.9113.8513.72
166.75160.87154.61
89.7887.8093.19
0.000.000.00
13.4512.3410.03
2.352.442.13
2.552.291.74
56.9754.9348.70
42.5241.5540.69
0.000.000.00
42.5241.5540.69
9.879.159.53
32.6632.4031.16
13.549.5719.37
Key metrics
47.4246.2844.56
24.27%24.50%24.50%
16.72%17.20%17.20%
11.20%15.20%
3.80%
4.00%
-82.72-31.64
0.380.49
0.270.19
79.0841.68
117.2103.1
Balance sheet
499.46358.16
206.14162.38
9.307.41
117.2483.40
11.5215.31
15.086.66
19.2719.16
68.1947.42
107.1777.20
88.3849.09
29.7821.32
58.6027.77
333.01252.94
Cash flow
12.3215.23
-96.00-41.42
85.5715.65
95.0446.87

Compounded growth

Standalone

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
Profit YoY (TTM)

Consolidated

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
Profit YoY (TTM)

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Filings & corporate actions

Recent announcements

Corporate actions

PurposeEx dateRecord datePayment date
Bonus issue 1:124 Mar 202624 Mar 2026
Right Issue of Equity Shares15 Jul 202515 Jul 2025

Board meetings

  • Board Meeting - Financial Results